ABRAXANE (paclitaxel) Bristol-myers Patent: 8,314,156 Expiration: Jun 9, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
Source
Drug Patent Expirations for the Week of June 9, 2024 Read Post »
This chart shows the drugs with the most patents in Portugal. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source
Which pharmaceutical drugs have the most drug patents in Portugal? Read Post »
Annual Drug Patent Expirations for SUNOSI Sunosi is a drug marketed by Axsome Malta and is included in one NDA. It is available from one supplier. There are twenty-eight patents…
Source
Annual Drug Patent Expirations for AXUMIN Axumin is a drug marketed by Blue Earth and is included in one NDA. It is available from one supplier. There are seven patents…
Source
Annual Drug Patent Expirations for RISVAN Risvan is a drug marketed by Labs Farms Rovi Sa and is included in one NDA. The generic ingredient in RISVAN is risperidone. Additional…
Source
Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are eighteen patents protecting…
Source
This chart shows the drugs with the most patents in Chile. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source
Which pharmaceutical drugs have the most drug patents in Chile? Read Post »
Annual Drug Patent Expirations for ALVAIZ Alvaiz is a drug marketed by Teva Pharms Inc and is included in one NDA. It is available from one supplier. The generic ingredient…
Source
Annual Drug Patent Expirations for TRALEMENT Tralement is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are two patents…
Source
Annual Drug Patent Expirations for SELENIOUS+ACID Selenious Acid is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. The generic ingredient…
Source